Merck
MRK
#40
Rank
C$508.78 B
Marketcap
C$206.22
Share price
-0.80%
Change (1 day)
78.49%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.90

According to Merck's latest financial reports the company's current EPS (TTM) is C$4.97. In 2025 the company made an earnings per share (EPS) of C$10.16 an increase over its 2024 EPS that were of C$9.40.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.90-51.81%
2025C$10.168.15%
2024C$9.404308.46%
2023C$0.21-97.32%
2022C$7.9710.92%
2021C$7.1884.68%
2020C$3.89-27.2%
2019C$5.3463.44%
2018C$3.27151.11%
2017C$1.30-54.58%
2016C$2.8630.21%
2015C$2.20-61.99%
2014C$5.79180.51%
2013C$2.06-31.82%
2012C$3.036.62%
2011C$2.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.14 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.76 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.82-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.02 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.24 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.13 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.56-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.95-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.40 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.90-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel